A carregar...
Galeterone and VNPT55 disrupt Mnk-eIF4E to inhibit prostate cancer cell migration and invasion
Metastatic castration-resistant prostate cancer (mCRPC) accounts for a high percentage of prostate cancer mortality. The proprietary compound galeterone (gal) was designed to inhibit proliferation of androgen/androgen receptor (AR)-dependent prostate cancer cell in vitro and in vivo and is currently...
Na minha lista:
| Publicado no: | FEBS J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118139/ https://ncbi.nlm.nih.gov/pubmed/27618366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.13895 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|